The present invention provides substituted benzimidazoles, pharmaceutical composition comprising the substituted benzimidazoles, and their use for preventing or treating a subject suffering from diseases or conditions associated with platelet activation aggregation and/or platelet activation.
本发明提供了取代
苯并咪唑,包括取代
苯并咪唑的药物组合物,并用于预防或治疗因血小板活化、聚集和/或血小板活化引起的疾病或症状的受试者。